Purdue Pharma L.P. Issues Statement on Opioid Promotion

STAMFORD, Conn. – February 9, 2018 – Purdue Pharma L.P. issued the following statement today:

We have restructured and significantly reduced our commercial operation and our sales representatives will no longer promote opioids to prescribers.

Going forward, questions and requests for information about our opioid products will be handled through direct communication with the highly experienced healthcare professionals that comprise our Medical Affairs department.

Purdue Pharma Medical Affairs can be contacted at (888) 726-7535 (option #1), PurdueMedInfo@pharma.com, or www.AskPurdueMedical.com.

ABOUT PURDUE PHARMA L.P.
Purdue Pharma L.P. is a privately held pharmaceutical company headquartered in Stamford, Conn. Purdue Pharma is part of a network of independent associated companies dedicated to providing patients and providers with innovative medicines. The company’s leadership and employees are committed to serving healthcare professionals, patients and caregivers by providing quality products and educational resources that make a positive impact on healthcare — and on lives. For more information, please visit www.purduepharma.com.

# # #

Media Inquiries:
Danielle Lewis
Director, Corporate Communications
Purdue Pharma L.P.
+1 203-588-7653
Danielle.Lewis@pharma.com

The prescription and illicit opioid abuse crisis is a multifaceted public health challenge, and as a manufacturer of prescription opioids, we have a responsibility to join the fight. At Purdue we are committed to lead our industry in helping address our nation's prescription and illicit opioid abuse crisis.

There is more to come – as we continue to work with partners and experts to deliver solutions. Below you will find additional information about our efforts.

Read our open letter about the opioid crisis.